Unraveling #JPM24: Insights From Citeline Reporters And Analysts

As it often does, this year's J.P. Morgan Healthcare Conference could set the tone for the rest of the year in biopharma. In Vivo revisits the key questions coming out of the 2024 event. 

More from Market Intelligence

More from In Vivo